|
Aug 13
|
Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution
|
|
Aug 6
|
Evotec SE to announce first half-year results 2025 on 13 August 2025
|
|
Aug 4
|
Sandoz bolsters in-house biosimilar manufacturing with Evotec acquisition
|
|
Jul 30
|
Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site
|
|
Jul 30
|
Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site
|
|
Jul 30
|
Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France
|
|
Jul 22
|
Morning Movers: Cleveland-Cliffs rallies after second quarter earnings release
|
|
Jul 21
|
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of Anticipated Earnings
|
|
Jul 21
|
Evotec Adjusts Revenue Guidance and Confirms Profit Guidance Anticipating a More Profitable Revenue Mix
|
|
Jul 21
|
Evotec SE Adjusts Revenue Guidance while Confirming Profit Guidance
|
|
Jun 29
|
Evotec (EVO) Joins NURTuRE-AKI Consortium to Advance Kidney Injury Drug Discovery
|
|
Jun 26
|
Basic Materials Roundup: Market Talk
|
|
Jun 25
|
Sector Update: Health Care Stocks Mixed Premarket Wednesday
|
|
Jun 25
|
Evotec Joins NURTuRE-AKI Consortium to Gain Multi-Omics-Based Molecular Understanding of Acute Kidney Injury
|
|
Apr 18
|
Evotec SE (EVO) (Q4 2024) Earnings Call Highlights: Strong Q4 Performance and Strategic ...
|
|
Apr 17
|
Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results
|
|
Oct 1
|
Even after rising 11% this past week, Evotec (ETR:EVT) shareholders are still down 84% over the past three years
|
|
Sep 26
|
Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies
|
|
May 30
|
Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases
|
|
May 28
|
Evotec and CHDI Foundation Extend Strategic Drug Discovery Collaboration in Huntington’s Disease
|